ELISA: too insensitive as a screening test

The CDC-approved two-tiered screening test for Lyme Disease is ineffective because …

The reason that most ELISA assays are inadequate as screening tests is that they were not designed by the manufacturers to be sensitive at the 95% confidence level, the level typically required for screening. In fact, Luger and Krause found up to a 56% false-negative rate (depending upon the commercial kit), when compared to their clinical diagnoses.

See ILADS’ Position Paper on the CDC’s Statement Regarding Lyme Diagnosis.


Category: Testing · Tags: , ,

Leave A Comment